دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A Half-Century of Progress in Health: The National Academy of Medicine at 50: Progress in Cancer Research, Prevention, and Care
R.L. Schilsky, S. Nass, M.M. Le Beau, and E.J. Benz, Jr.
doi : 10.1056/NEJMp2007839
N Engl J Med 2020; 383:897-900
Public Health Decision Making during Covid-19 — Fulfilling the CDC Pledge to the American People
S.A. Rasmussen and D.J. Jamieson
doi : 10.1056/NEJMp2026045
N Engl J Med 2020; 383:901-903
Long-Term Care Policy after Covid-19 — Solving the Nursing Home Crisis
R.M. Werner, A.K. Hoffman, and N.B. Coe
doi : 10.1056/NEJMp2014811
N Engl J Med 2020; 383:903-905
Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
M.E. Deming, N.L. Michael, M. Robb, M.S. Cohen, and K.M. Neuzil
doi : 10.1056/NEJMp2020076
N Engl J Med 2020; 383:e63
Weight Loss in Underserved Patients — A Cluster-Randomized Trial
P.T. Katzmarzyk and Others
doi : 10.1056/NEJMoa2007448
N Engl J Med 2020; 383:909-918
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
S. Paganoni and Others
doi : 10.1056/NEJMoa1916945
N Engl J Med 2020; 383:919-930
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
P.K. Paik and Others
doi : 10.1056/NEJMoa2004407
N Engl J Med 2020; 383:931-943
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
J. Wolf and Others
doi : 10.1056/NEJMoa2002787
N Engl J Med 2020; 383:944-957
Spectrum of Fibrotic Lung Diseases
M. Wijsenbeek and V. Cottin
doi : 10.1056/NEJMra2005230
N Engl J Med 2020; 383:958-968
SARS-CoV-2 Infection of Airway Cells
C. Ehre
doi : 10.1056/NEJMicm2023328
N Engl J Med 2020; 383:969
Conjunctival Squamous-Cell Carcinoma
G. Vicini and C. Mazzini
doi : 10.1056/NEJMicm2002512
N Engl J Med 2020; 383:e65
A Curve Ball
M. Mukaigawara, R. Manesh, M. Kinjo, S. Sugita, and A.P.J. Olson
doi : 10.1056/NEJMcps1910306
N Engl J Med 2020; 383:970-975
Addressing Disparities in the Management of Obesity in Primary Care Settings
T.A. Wadden and A.G. Tsai
doi : 10.1056/NEJMe2025728
N Engl J Med 2020; 383:977-978
Incremental Gains in the Battle against ALS
M. Benatar and M.P. McDermott
doi : 10.1056/NEJMe2021144
N Engl J Med 2020; 383:979-980
Audio Interview: Understanding Antibody Testing in Covid-19
E.J. Rubin, L.R. Baden, and S. Morrissey
doi : 10.1056/NEJMe2028992
N Engl J Med 2020; 383:e85
Reopening Primary Schools during the Pandemic
M. Levinson, M. Cevik, and M. Lipsitch
doi : 10.1056/NEJMms2024920
N Engl J Med 2020; 383:981-985
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
doi : 10.1056/NEJMc2001362
N Engl J Med 2020; 383:986-989
Remdesivir for the Treatment of Covid-19 — Preliminary Report
doi : 10.1056/NEJMc2022236
N Engl J Med 2020; 383:992-994
Invasive or Conservative Strategy for Stable Coronary Diseasee
doi : 10.1056/NEJMc2024008
N Engl J Med 2020; 383:e66
A Half-Century of Progress in Health: The National Academy of Medicine at 50: Progress in Cancer Research, Prevention, and Care
R.L. Schilsky, S. Nass, M.M. Le Beau, and E.J. Benz, Jr.
doi : 10.1056/NEJMp2007839
N Engl J Med 2020; 383:897-900
Public Health Decision Making during Covid-19 — Fulfilling the CDC Pledge to the American People
S.A. Rasmussen and D.J. Jamieson
doi : 10.1056/NEJMp2026045
N Engl J Med 2020; 383:901-903
Long-Term Care Policy after Covid-19 — Solving the Nursing Home Crisis
R.M. Werner, A.K. Hoffman, and N.B. Coe
doi : 10.1056/NEJMp2014811
N Engl J Med 2020; 383:903-905
Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
M.E. Deming, N.L. Michael, M. Robb, M.S. Cohen, and K.M. Neuzil
doi : 10.1056/NEJMp2020076
N Engl J Med 2020; 383:e63
Weight Loss in Underserved Patients — A Cluster-Randomized Trial
P.T. Katzmarzyk and Others
doi : 10.1056/NEJMoa2007448
N Engl J Med 2020; 383:909-918
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
S. Paganoni and Others
doi : 10.1056/NEJMoa1916945
N Engl J Med 2020; 383:919-930
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
P.K. Paik and Others
doi : 10.1056/NEJMoa2004407
N Engl J Med 2020; 383:931-943
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
J. Wolf and Others
doi : 10.1056/NEJMoa2002787
N Engl J Med 2020; 383:944-957
Spectrum of Fibrotic Lung Diseases
M. Wijsenbeek and V. Cottin
doi : 10.1056/NEJMra2005230
N Engl J Med 2020; 383:958-968
SARS-CoV-2 Infection of Airway Cells
C. Ehre
doi : 10.1056/NEJMicm2023328
N Engl J Med 2020; 383:969
Conjunctival Squamous-Cell Carcinoma
G. Vicini and C. Mazzini
doi : 10.1056/NEJMicm2002512
N Engl J Med 2020; 383:e65
A Curve Ball
M. Mukaigawara, R. Manesh, M. Kinjo, S. Sugita, and A.P.J. Olson
doi : 10.1056/NEJMcps1910306
N Engl J Med 2020; 383:970-975
Addressing Disparities in the Management of Obesity in Primary Care Settings
T.A. Wadden and A.G. Tsai
doi : 10.1056/NEJMe2025728
N Engl J Med 2020; 383:977-978
Incremental Gains in the Battle against ALS
M. Benatar and M.P. McDermott
doi : 10.1056/NEJMe2021144
N Engl J Med 2020; 383:979-980
Audio Interview: Understanding Antibody Testing in Covid-19
E.J. Rubin, L.R. Baden, and S. Morrissey
doi : 10.1056/NEJMe2028992
N Engl J Med 2020; 383:e85
Reopening Primary Schools during the Pandemic
M. Levinson, M. Cevik, and M. Lipsitch
doi : 10.1056/NEJMms2024920
N Engl J Med 2020; 383:981-985
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
doi : 10.1056/NEJMc2001362
N Engl J Med 2020; 383:986-989
Remdesivir for the Treatment of Covid-19 — Preliminary Report
doi : 10.1056/NEJMc2022236
N Engl J Med 2020; 383:992-994
Invasive or Conservative Strategy for Stable Coronary Diseasee
doi : 10.1056/NEJMc2024008
N Engl J Med 2020; 383:e66
